Sandra Apenteng
Rheumatology · Glastonbury, CTNPI 1801359138
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 276 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations.
Across 276 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$929
- Johnson & Johnson$823
- UCB, Inc.$636
- Mallinckrodt Hospital Products Inc.$434
- AstraZeneca$424
- plus $2K from 19 others
What the payments were for
- Food & beverage$6,23198%
- Education$1132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $1,221 |
| Amgen | 34 | $929 |
| Johnson & Johnson(2 entities) | 41 | $823 |
| UCB, Inc. | 35 | $636 |
| Mallinckrodt Hospital Products Inc. | 16 | $434 |
| AstraZeneca(2 entities) | 10 | $424 |
| ANI Pharmaceuticals, Inc. | 22 | $352 |
| Actelion Pharmaceuticals US, Inc. | 6 | $280 |
| E.r. Squibb & Sons, L.L.C. | 10 | $210 |
| Novartis | 6 | $147 |
| Sanofi | 4 | $127 |
| Lilly USA, LLC | 6 | $123 |
| Genentech USA, Inc. | 6 | $122 |
| Octapharma USA, Inc. | 4 | $96 |
| Fresenius Kabi USA, LLC | 3 | $92 |
| Sobi, Inc | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Boehringer Ingelheim | 2 | $44 |
| Almatica Pharma LLC | 2 | $43 |
| Endo USA, Inc. | 1 | $26 |
| Invivyd Inc | 1 | $25 |
| Sandoz | 1 | $25 |
| Organon | 1 | $25 |
| GSK | 1 | $24 |
| Pfizer | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,344 in reported general payments places this provider in the 75th percentile of 118 rheumatology providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 20 | $630 |
| Prednisone | 58 | $571 |
| MethotrexateMethotrexate Sodium | 16 | $506 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Glastonbury
- Christopher ScolaGlastonbury$20K
- Ioana StanescuGlastonbury$19K
- John VischioGlastonbury$10K
- Kenneth MillerDanbury$873K
- Robert SchoenGuilford$638K
- Bret SohnStamford$447K
- Fotios KoumpourasNorth Haven$314K
- James SeiboldFarmington$300K
- Michael SpiegelDanbury$215K
- John MagaldiTorrington$157K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.